| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 3 |
| 1 | TACROLIMUS | 3 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 3 | TACROLIMUS OINTMENT 0.1% | 3 |
| 4 | DEXAMETHASONE | 2 |
| 5 | DEXAMETHASONE 1.5 MG | 2 |
| 6 | GLECAPREVIR AND PIBRENTASVIR | 2 |
| 7 | PREDNISOLONE | 2 |
| 8 | PREDNISOLONE ORAL | 2 |
| 9 | PREDNISOLONE ORAL SOLUTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 1 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 2 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 3 | GLECAPREVIR AND PIBRENTASVIR | 2 | 0.0002 |
| 4 | VELPATASVIR AND SOFOSBUVIR | 2 | 0.0002 |
| 5 | MICAFUNGIN SODIUM | 1 | 0.0002 |
| 6 | REMDESIVIR | 2 | 0.0002 |
| 7 | RILPIVIRINE | 1 | 0.0001 |
| 8 | ITRACONAZOLE | 1 | 0.0001 |
| 9 | CEFEPIME HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 4 | 0.0002 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 2 | Hepatitis C Virus NS5A Inhibitor [EPC] | 6 | 0.0001 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 1 | 0.0000 |